Equities

Mauna Kea Technologies SA

Mauna Kea Technologies SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)0.187
  • Today's Change0.007 / 3.89%
  • Shares traded390.12k
  • 1 Year change-58.72%
  • Beta1.3123
Data delayed at least 15 minutes, as of Nov 14 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments8.013.1512
Total Receivables, Net3.078.423.39
Total Inventory2.863.173.01
Prepaid expenses0.390.340.37
Other current assets, total0.00--0.00
Total current assets141519
Property, plant & equipment, net1.161.732.36
Goodwill, net------
Intangibles, net2.012.703.37
Long term investments5.430.300.36
Note receivable - long term------
Other long term assets0.000.000.00
Total assets232025
LIABILITIES
Accounts payable2.771.271.67
Accrued expenses1.441.571.82
Notes payable/short-term debt000
Current portion long-term debt/capital leases162.261.81
Other current liabilities, total6.167.552.05
Total current liabilities27137.34
Total long term debt132727
Total debt302929
Deferred income tax------
Minority interest------
Other liabilities, total0.070.120.86
Total liabilities404035
SHAREHOLDERS EQUITY
Common stock2.461.861.78
Additional paid-in capital7.620.79112
Retained earnings (accumulated deficit)(27)(23)(124)
Treasury stock - common(0.02)(0.06)(0.06)
Unrealized gain (loss)------
Other equity, total(0.84)0.580.17
Total equity(17)(20)(10)
Total liabilities & shareholders' equity232025
Total common shares outstanding614645
Treasury shares - common primary issue0.110.130.08
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.